-
1
-
-
77955635233
-
Cancer statistics
-
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
3
-
-
84867127613
-
Trends in cancer mortality in China: An update
-
Guo P, Huang ZL, Yu P, Li K. Trends in cancer mortality in China: an update. Ann Oncol. 2012;23:2755–2762.
-
(2012)
Ann Oncol
, vol.23
, pp. 2755-2762
-
-
Guo, P.1
Huang, Z.L.2
Yu, P.3
Li, K.4
-
4
-
-
42049099094
-
Systemic chemotherapy for advanced non-small cell lung cancer: Recent advances and future directions
-
Ramalingam S, Belani C. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist. 2008;13 Suppl 1:5–13.
-
(2008)
Oncologist
, vol.13
, pp. 5-13
-
-
Ramalingam, S.1
Belani, C.2
-
5
-
-
84891960758
-
Chemokines in tumor progression and metastasis
-
Sarvaiya PJ, Guo D, Ulasov I, Gabikian P, Lesniak MS. Chemokines in tumor progression and metastasis. Oncotarget. 2013;4:2171–2185.
-
(2013)
Oncotarget
, vol.4
, pp. 2171-2185
-
-
Sarvaiya, P.J.1
Guo, D.2
Ulasov, I.3
Gabikian, P.4
Lesniak, M.S.5
-
6
-
-
84861071963
-
The emerging role of CXC chemokines and their receptors in cancer
-
Vinader V, Afarinkia K. The emerging role of CXC chemokines and their receptors in cancer. Future Med Chem. 2012;4:853–867.
-
(2012)
Future Med Chem
, vol.4
, pp. 853-867
-
-
Vinader, V.1
Afarinkia, K.2
-
7
-
-
0031280098
-
Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry
-
Moriuchi M, Moriuchi H, Turner W, Fauci AS. Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. J Immunol. 1997;159:4322–4329.
-
(1997)
J Immunol
, vol.159
, pp. 4322-4329
-
-
Moriuchi, M.1
Moriuchi, H.2
Turner, W.3
Fauci, A.S.4
-
8
-
-
0032540493
-
Genomic organization and promoter characterization of human CXCR4 gene
-
Caruz A, Samsom M, Alonso JM, et al. Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett. 1998;426:271–278.
-
(1998)
FEBS Lett
, vol.426
, pp. 271-278
-
-
Caruz, A.1
Samsom, M.2
Alonso, J.M.3
-
9
-
-
84885237107
-
Emerging targets in cancer management: Role of the CXCL12/CXCR4 axis
-
Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A. Emerging targets in cancer management: role of the CXCL12/CXCR4 axis. Onco Targets Ther. 2013;6:1347–1361.
-
(2013)
Onco Targets Ther
, vol.6
, pp. 1347-1361
-
-
Cojoc, M.1
Peitzsch, C.2
Trautmann, F.3
Polishchuk, L.4
Telegeev, G.D.5
Dubrovska, A.6
-
10
-
-
84871412842
-
A review on CXCR4/CXCL12 axis in oncology: No place to hide
-
Domanska UM, Kruizinga RC, Nagengast WB, et al. A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur J Cancer. 2013;49:219–230.
-
(2013)
Eur J Cancer
, vol.49
, pp. 219-230
-
-
Domanska, U.M.1
Kruizinga, R.C.2
Nagengast, W.B.3
-
11
-
-
78449300594
-
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
-
Sun X, Cheng G, Hao M, et al. CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev. 2010;29:709–722.
-
(2010)
Cancer Metastasis Rev
, vol.29
, pp. 709-722
-
-
Sun, X.1
Cheng, G.2
Hao, M.3
-
12
-
-
84902536339
-
Expression of CXCR4 and breast cancer prognosis: A systematic review and meta-analysis
-
Zhang Z, Ni C, Chen W, et al. Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis. BMC Cancer. 2014;14:49.
-
(2014)
BMC Cancer
, vol.14
, pp. 49
-
-
Zhang, Z.1
Ni, C.2
Chen, W.3
-
13
-
-
84883171439
-
The Role of chemokine receptor CXCR4 in breast cancer metastasis
-
Mukherjee D, Zhao J. The Role of chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer Res. 2013;3:46–57.
-
(2013)
Am J Cancer Res
, vol.3
, pp. 46-57
-
-
Mukherjee, D.1
Zhao, J.2
-
14
-
-
84873819633
-
CXCR4 and axillary lymph nodes: Review of a potential biomarker for breast cancer metastasis
-
Hiller D, Chu QD. CXCR4 and axillary lymph nodes: review of a potential biomarker for breast cancer metastasis. Int J Breast Cancer. 2011;2011:420981.
-
(2011)
Int J Breast Cancer. 2011
-
-
Hiller, D.1
Chu, Q.D.2
-
15
-
-
34248363901
-
CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma
-
Yang YC, Lee ZY, Wu CC, Chen TC, Chang CL, Chen CP. CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma. Int J Gynecol Cancer. 2007;17:676–686.
-
(2007)
Int J Gynecol Cancer
, vol.17
, pp. 676-686
-
-
Yang, Y.C.1
Lee, Z.Y.2
Wu, C.C.3
Chen, T.C.4
Chang, C.L.5
Chen, C.P.6
-
16
-
-
33846544434
-
Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer
-
Kodama J, Hasengaowa D, Kusumoto T, et al. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann Oncol. 2007;18:70–76.
-
(2007)
Ann Oncol
, vol.18
, pp. 70-76
-
-
Kodama, J.1
Hasengaowa, D.2
Kusumoto, T.3
-
17
-
-
84869506748
-
The role of CXCR3 and CXCR4 in colorectal cancer metastasis
-
Murakami T, Kawada K, Iwamoto M, et al. The role of CXCR3 and CXCR4 in colorectal cancer metastasis. Int J Cancer. 2013;132:276–287.
-
(2013)
Int J Cancer
, vol.132
, pp. 276-287
-
-
Murakami, T.1
Kawada, K.2
Iwamoto, M.3
-
18
-
-
0038079014
-
The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases
-
Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 2003;63:3833–3839.
-
(2003)
Cancer Res
, vol.63
, pp. 3833-3839
-
-
Zeelenberg, I.S.1
Ruuls-Van Stalle, L.2
Roos, E.3
-
19
-
-
84865069744
-
CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma
-
Gros SJ, Graeff H, Drenckhan A, et al. CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma. In Vivo. 2012;26:711–718.
-
(2012)
In Vivo
, vol.26
, pp. 711-718
-
-
Gros, S.J.1
Graeff, H.2
Drenckhan, A.3
-
20
-
-
84867634937
-
Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer
-
Gros SJ, Kurschat N, Drenckhan A, et al. Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer. Plos One. 2012;7:e47287.
-
(2012)
Plos One
, vol.7
-
-
Gros, S.J.1
Kurschat, N.2
Drenckhan, A.3
-
21
-
-
80052204997
-
High expression of CXCR4 and CXCR7 predicts poor survival in gallbladder cancer
-
Yao X, Zhou L, Han S, Chen Y. High expression of CXCR4 and CXCR7 predicts poor survival in gallbladder cancer. J Int Med Res. 2011;39:1253–1264.
-
(2011)
J Int Med Res
, vol.39
, pp. 1253-1264
-
-
Yao, X.1
Zhou, L.2
Han, S.3
Chen, Y.4
-
22
-
-
84907207296
-
Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer
-
Huang CS, Tang SJ, Chung LY, et al. Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer. J Am Soc Nephrol. 2014;25(7):1486–1495.
-
(2014)
J am Soc Nephrol
, vol.25
, Issue.7
, pp. 1486-1495
-
-
Huang, C.S.1
Tang, S.J.2
Chung, L.Y.3
-
23
-
-
84868095010
-
Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells
-
Wang L, Huang T, Chen W, et al. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells. Oncol Rep. 2012;28:2043–2048.
-
(2012)
Oncol Rep
, vol.28
, pp. 2043-2048
-
-
Wang, L.1
Huang, T.2
Chen, W.3
-
24
-
-
33751319000
-
Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis
-
Pan J, Mestas J, Burdick MD, et al. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer. 2006;5:56.
-
(2006)
Mol Cancer
, vol.5
, pp. 56
-
-
Pan, J.1
Mestas, J.2
Burdick, M.D.3
-
25
-
-
75149186207
-
Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome
-
Xiang Z, Zeng Z, Tang Z, et al. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome. Cancer J. 2009;15:519–525.
-
(2009)
Cancer J
, vol.15
, pp. 519-525
-
-
Xiang, Z.1
Zeng, Z.2
Tang, Z.3
-
26
-
-
33745888428
-
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4
-
Schimanski CC, Bahre R, Gockel I, et al. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer. 2006;95:210–217.
-
(2006)
Br J Cancer
, vol.95
, pp. 210-217
-
-
Schimanski, C.C.1
Bahre, R.2
Gockel, I.3
-
27
-
-
83055178990
-
Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway
-
Wang J, Cai J, Han F, et al. Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway. Int J Gynecol Cancer. 2011;21:981–987.
-
(2011)
Int J Gynecol Cancer
, vol.21
, pp. 981-987
-
-
Wang, J.1
Cai, J.2
Han, F.3
-
28
-
-
78649700451
-
Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion
-
Miyanishi N, Suzuki Y, Simizu S, Kuwabara Y, Banno K, Umezawa K. Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion. Biochem Biophys Res Commun. 2010;403:154–159.
-
(2010)
Biochem Biophys Res Commun
, vol.403
, pp. 154-159
-
-
Miyanishi, N.1
Suzuki, Y.2
Simizu, S.3
Kuwabara, Y.4
Banno, K.5
Umezawa, K.6
-
29
-
-
78651407343
-
Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation
-
Park HD, Lee Y, Oh YK, et al. Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation. Oncogene. 2011;30:201–211.
-
(2011)
Oncogene
, vol.30
, pp. 201-211
-
-
Park, H.D.1
Lee, Y.2
Oh, Y.K.3
-
30
-
-
84892949720
-
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
-
Wong D, Kandagatla P, Korz W, Chinni SR. Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis. BMC Urol. 2014;14:12.
-
(2014)
BMC Urol
, vol.14
, pp. 12
-
-
Wong, D.1
Kandagatla, P.2
Korz, W.3
Chinni, S.R.4
-
31
-
-
84881608628
-
Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model
-
Cho KS, Yoon SJ, Lee JY, et al. Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model. Oncol Lett. 2013;6:933–938.
-
(2013)
Oncol Lett
, vol.6
, pp. 933-938
-
-
Cho, K.S.1
Yoon, S.J.2
Lee, J.Y.3
-
32
-
-
84880854554
-
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
-
Conley-LaComb MK, Saliganan A, Kandagatla P, Chen YQ, Cher ML, Chinni SR. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling. Mol Cancer. 2013;12:85.
-
(2013)
Mol Cancer
, vol.12
, pp. 85
-
-
Conley-Lacomb, M.K.1
Saliganan, A.2
Kandagatla, P.3
Chen, Y.Q.4
Cher, M.L.5
Chinni, S.R.6
-
33
-
-
42649122953
-
Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells
-
Hashimoto I, Koizumi K, Tatematsu M, et al. Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer. 2008;44:1022–1029.
-
(2008)
Eur J Cancer
, vol.44
, pp. 1022-1029
-
-
Hashimoto, I.1
Koizumi, K.2
Tatematsu, M.3
-
34
-
-
33644546367
-
Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer
-
Yasumoto K, Koizumi K, Kawashima A, et al. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 2006;66:2181–2187.
-
(2006)
Cancer Res
, vol.66
, pp. 2181-2187
-
-
Yasumoto, K.1
Koizumi, K.2
Kawashima, A.3
-
36
-
-
79951875085
-
CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth
-
Beider K, Begin M, Abraham M, et al. CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. Exp Hematol. 2011;39:282–292.
-
(2011)
Exp Hematol
, vol.39
, pp. 282-292
-
-
Beider, K.1
Begin, M.2
Abraham, M.3
-
37
-
-
66149150580
-
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
-
Azab AK, Runnels JM, Pitsillides C, et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood. 2009;113:4341–4351.
-
(2009)
Blood
, vol.113
, pp. 4341-4351
-
-
Azab, A.K.1
Runnels, J.M.2
Pitsillides, C.3
-
38
-
-
0036606772
-
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin’s lymphoma
-
Bertolini F, Dell’Agnola C, Mancuso P, et al. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin’s lymphoma. Cancer Res. 2002;62:3106–3112.
-
(2002)
Cancer Res
, vol.62
, pp. 3106-3112
-
-
Bertolini, F.1
Dell’Agnola, C.2
Mancuso, P.3
-
39
-
-
84893093656
-
CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells
-
Choi YH, Burdick MD, Strieter BA, Mehrad B, Strieter RM. CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells. Mol Cancer Res. 2014;12:38–47.
-
(2014)
Mol Cancer Res
, vol.12
, pp. 38-47
-
-
Choi, Y.H.1
Burdick, M.D.2
Strieter, B.A.3
Mehrad, B.4
Strieter, R.M.5
-
40
-
-
84874712239
-
Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer
-
Al Zobair AA, Al Obeidy BF, Yang L, et al. Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer. Oncol Rep. 2013;29:1524–1532.
-
(2013)
Oncol Rep
, vol.29
, pp. 1524-1532
-
-
Al Zobair, A.A.1
Al Obeidy, B.F.2
Yang, L.3
-
41
-
-
84883176178
-
CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential
-
Wald O, Shapira OM, Izhar U. CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential. Theranostics. 2013;3:26–33.
-
(2013)
Theranostics
, vol.3
, pp. 26-33
-
-
Wald, O.1
Shapira, O.M.2
Izhar, U.3
-
42
-
-
85027918527
-
In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer
-
Fahham D, Weiss ID, Abraham M, et al. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer. J Thorac Cardiovasc Surg. 2012;144:1167–1175.e1.
-
(2012)
J Thorac Cardiovasc Surg
, vol.144
, pp. 1167-1175
-
-
Fahham, D.1
Weiss, I.D.2
Abraham, M.3
-
43
-
-
67650742534
-
CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer
-
Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, Strieter RM. CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. BMC Cancer. 2009;9:213.
-
(2009)
BMC Cancer
, vol.9
, pp. 213
-
-
Reckamp, K.L.1
Figlin, R.A.2
Burdick, M.D.3
Dubinett, S.M.4
Elashoff, R.M.5
Strieter, R.M.6
-
44
-
-
60949093573
-
CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival
-
Wagner PL, Hyjek E, Vazquez MF, et al. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg. 2009;137:615–621.
-
(2009)
J Thorac Cardiovasc Surg
, vol.137
, pp. 615-621
-
-
Wagner, P.L.1
Hyjek, E.2
Vazquez, M.F.3
-
45
-
-
23844534811
-
Reporting recommendations for tumor marker prognostic studies (REMARK)
-
McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst. 2005;97:1180–1184.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1180-1184
-
-
McShane, L.M.1
Altman, D.G.2
Sauerbrei, W.3
-
46
-
-
17944380542
-
Role of p53 as a prognostic factor for survival in lung cancer: A systematic review of the literature with a meta-analysis
-
Steels E, Paesmans M, Berghmans T, et al. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J. 2001;18:705–719.
-
(2001)
Eur Respir J
, vol.18
, pp. 705-719
-
-
Steels, E.1
Paesmans, M.2
Berghmans, T.3
-
49
-
-
0029898186
-
Meta-analysis in the design and monitoring of clinical trials
-
discussion 1249–1252
-
Der Simonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med. 1996;15:1237–1248; discussion 1249–1252.
-
(1996)
Stat Med
, vol.15
, pp. 1237-1248
-
-
Der Simonian, R.1
-
50
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
-
(1997)
BMJ
, vol.315
, pp. 629-634
-
-
Egger, M.1
Davey Smith, G.2
Schneider, M.3
Minder, C.4
-
51
-
-
79959906050
-
CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer
-
Otsuka S, Klimowicz AC, Kopciuk K, et al. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer. J Thorac Oncol. 2011;6:1169–1178.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 1169-1178
-
-
Otsuka, S.1
Klimowicz, A.C.2
Kopciuk, K.3
-
52
-
-
84928233689
-
Expression of CXCR4 in lung cancer tissue array and clinical significance
-
Zhang Y, Li H, Qi Y, Haofeng C, Shinan F, Chenkun W. Expression of CXCR4 in lung cancer tissue array and clinical significance. Chiese Medicine. 2012;36(2):78–82.
-
(2012)
Chiese Medicine
, vol.36
, Issue.2
, pp. 78-82
-
-
Zhang, Y.1
Li, H.2
Qi, Y.3
Haofeng, C.4
Shinan, F.5
Chenkun, W.6
-
53
-
-
84889039588
-
Multimodality imaging of CXCR4 in cancer: Current status towards clinical translation
-
Nayak TR, Hong H, Zhang Y, Cai W. Multimodality imaging of CXCR4 in cancer: current status towards clinical translation. Curr Mol Med. 2013;13:1538–1548.
-
(2013)
Curr Mol Med
, vol.13
, pp. 1538-1548
-
-
Nayak, T.R.1
Hong, H.2
Zhang, Y.3
Cai, W.4
-
54
-
-
84888294650
-
Chemokine receptor CXCR4: Role in gastrointestinal cancer
-
Lombardi L, Tavano F, Morelli F, Latiano TP, Di Sebastiano P, Maiello E. Chemokine receptor CXCR4: role in gastrointestinal cancer. Crit Rev Oncol Hematol. 2013;88:696–705.
-
(2013)
Crit Rev Oncol Hematol
, vol.88
, pp. 696-705
-
-
Lombardi, L.1
Tavano, F.2
Morelli, F.3
Latiano, T.P.4
Di Sebastiano, P.5
Maiello, E.6
-
55
-
-
79551625942
-
CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization
-
Liekens S, Schols D, Hatse S. CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization. Curr Pharm Des. 2010;16:3903–3920.
-
(2010)
Curr Pharm Des
, vol.16
, pp. 3903-3920
-
-
Liekens, S.1
Schols, D.2
Hatse, S.3
-
56
-
-
33751071832
-
Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines
-
Liu YL, Yu JM, Song XR, Wang XW, Xing LG, Gao BB. Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines. Cancer Biol Ther. 2006;5:1320–1326.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 1320-1326
-
-
Liu, Y.L.1
Yu, J.M.2
Song, X.R.3
Wang, X.W.4
Xing, L.G.5
Gao, B.B.6
-
57
-
-
33751256842
-
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: Implications for angiogenesis and glioma cell invasion
-
Zagzag D, Lukyanov Y, Lan L, et al. Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest. 2006;86:1221–1232.
-
(2006)
Lab Invest
, vol.86
, pp. 1221-1232
-
-
Zagzag, D.1
Lukyanov, Y.2
Lan, L.3
-
58
-
-
77951703977
-
Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer
-
Imai H, Sunaga N, Shimizu Y, et al. Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer. Int J Immunopathol Pharmacol. 2010;23:153–164.
-
(2010)
Int J Immunopathol Pharmacol
, vol.23
, pp. 153-164
-
-
Imai, H.1
Sunaga, N.2
Shimizu, Y.3
-
59
-
-
51049091703
-
Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis
-
Suzuki M, Mohamed S, Nakajima T, et al. Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis. Int J Oncol. 2008;33:113–119.
-
(2008)
Int J Oncol
, vol.33
, pp. 113-119
-
-
Suzuki, M.1
Mohamed, S.2
Nakajima, T.3
-
60
-
-
79953267058
-
Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer
-
Wang M, Chen GY, Song HT, Hong X, Yang ZY, Sui GJ. Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer. Exp Ther Med. 2011;2:517–522.
-
(2011)
Exp Ther Med
, vol.2
, pp. 517-522
-
-
Wang, M.1
Chen, G.Y.2
Song, H.T.3
Hong, X.4
Yang, Z.Y.5
Sui, G.J.6
-
61
-
-
84862225345
-
Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer
-
Zhou Z, Chen ZW, Yang XH, et al. Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer. J Exp Clin Cancer Res. 2012;31:34.
-
(2012)
J Exp Clin Cancer Res
, vol.31
, pp. 34
-
-
Zhou, Z.1
Chen, Z.W.2
Yang, X.H.3
-
62
-
-
78651304334
-
High-level CXCR4 expression correlates with brain-specific metastasis of non-small cell lung cancer
-
Chen G, Wang Z, Liu XY, Liu FY. High-level CXCR4 expression correlates with brain-specific metastasis of non-small cell lung cancer. World J Surg. 2011;35:56–61.
-
(2011)
World J Surg
, vol.35
, pp. 56-61
-
-
Chen, G.1
Wang, Z.2
Liu, X.Y.3
Liu, F.Y.4
-
63
-
-
77952553533
-
Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung
-
Minamiya Y, Saito H, Takahashi N, et al. Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung. Lung Cancer. 2010;68:466–471.
-
(2010)
Lung Cancer
, vol.68
, pp. 466-471
-
-
Minamiya, Y.1
Saito, H.2
Takahashi, N.3
-
64
-
-
56149118023
-
Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis
-
Na IK, Scheibenbogen C, Adam C, et al. Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis. Hum Pathol. 2008;39:1751–1755.
-
(2008)
Hum Pathol
, vol.39
, pp. 1751-1755
-
-
Na, I.K.1
Scheibenbogen, C.2
Adam, C.3
-
65
-
-
28544440733
-
Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells
-
Su L, Zhang J, Xu H, et al. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. Clin Cancer Res. 2005;11:8273–8280.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 8273-8280
-
-
Su, L.1
Zhang, J.2
Xu, H.3
-
66
-
-
2342432307
-
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: Pattern of expression and correlation with outcome
-
Spano JP, Andre F, Morat L, et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol. 2004;15:613–617.
-
(2004)
Ann Oncol
, vol.15
, pp. 613-617
-
-
Spano, J.P.1
Re, F.2
Morat, L.3
-
67
-
-
84925282689
-
CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications
-
Chinese
-
Hu T, Yao Y, Yu S, et al. [CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications]. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34:153–158. Chinese.
-
(2014)
Nan Fang Yi Ke Da Xue Xue Bao
, vol.34
, pp. 153-158
-
-
Hu, T.1
Yao, Y.2
Yu, S.3
-
68
-
-
84928236845
-
Expression of CXCR4 in lung cancer tissue array and clinical significance
-
Zhang Y, Li H, Qi Y, Haofeng C, Shinan F, Chenkun W. Expression of CXCR4 in lung cancer tissue array and clinical significance. Guide of China Medicine. 2012;10(36):448–450.
-
(2012)
Guide of China Medicine
, vol.10
, Issue.36
, pp. 448-450
-
-
Zhang, Y.1
Li, H.2
Qi, Y.3
Haofeng, C.4
Shinan, F.5
Chenkun, W.6
-
69
-
-
84928230672
-
Expression and Clinical Significance of Chemokine Receptor CXCR4 in Lung Cancer and Its Corresponding Lymph Node Metastasis
-
Xiao T, Ren Y, Chen X, Liang L. Expression and Clinical Significance of Chemokine Receptor CXCR4 in Lung Cancer and Its Corresponding Lymph Node Metastasis. Clin J Med Offic. 2009;37(3):408–410.
-
(2009)
Clin J Med Offic
, vol.37
, Issue.3
, pp. 408-410
-
-
Xiao, T.1
Ren, Y.2
Chen, X.3
Liang, L.4
|